A Fast-Mimicking Diet Combined With Vitamin C May Kill Cancer Cells

Article

Study examines the effect of a low-calorie, plant-based diet combined with vitamin C in helping to kill cancer cells.

A fast-mimicking diet could be more effective in treating some cancers when combined with vitamin C, according to a new research published in Nature Communications.

Fasting remains a challenging option for patients with cancer, according to the study; however, a low-calorie, plant-based diet is a safer, more feasible option. This diet causes the cells to react as if the body was fasting. Combined with vitamin C, this diet has the potential to replace more toxic cancer treatments.

The studies were conducted on mouse models of colorectal cancer. The researchers found that the combination of a fast-mimicking diet and vitamin C delayed tumor progression in some models and caused disease regression in some cases. Although prior research on the benefits of vitamin C in fighting cancer has yielded mixed results, researchers wanted to see whether the tumor-fighting properties of vitamin C could be enhanced by a fast-mimicking diet and create an environment unsuitable for cancer cells but safe for normal cells.

Researchers found that both a fast-mimicking diet and vitamin C reduced cancer on its own, according to the press release. When used individually, both methods caused a minor increase in cancer cell death; however, researchers said that when used together, almost all cancerous cells were killed. The results were only seen in the KRAS mutation, which occurs in approximately 25% of all human cancers and up to 50% in all colorectal cancers. KRAS mutation is regarded as one of the most challenging in cancer research, according to the study.

"In this study, we observed how fasting-mimicking diet cycles are able to increase the effect of pharmacological doses of vitamin C against KRAS-mutated cancers. This occurs through the regulation of the levels of iron and of the molecular mechanisms involved in oxidative stress. The results particularly pointed to a gene that regulates iron levels: heme-oxygenase-1,” Maira Di Tano, study co-author, of the IFOM, FIRC Institute of Molecular Oncology in Milan, Italy, said in the press release.

The study authors said that cancer will eventually be treated with low-toxicity drugs in a manner similar to how antibiotics are used, according to the press release.

Reference:

A combo of fasting plus vitamin C is effective for hard-to-treat cancers, study shows (Press release), Los Angeles, CA, May 12, 2020, ScienceDaily, accessed July 28, 2020

Related Videos
Therapy session -- Image credit: pressmaster | stock.adobe.com
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Multiple myeloma awareness -- Image credit: Fauzi | stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.